ProQR spins out skin disease drug into nonprofit-backed startup

ProQR spins out skin disease drug into nonprofit-backed startup

Source: 
Fierce Biotech
snippet: 

ProQR Therapeutics has spun out its early-phase oligonucleotide treatment for a rare inherited skin disorder to form a new company. The spinout, Wings Therapeutics, starts life with a phase 1/2 asset and funding from a disease-focused nonprofit.